Mineralocorticoid Receptor Antagonists and the Metabolic Syndrome
- 19 June 2010
- journal article
- review article
- Published by Springer Science and Business Media LLC in Current Hypertension Reports
- Vol. 12 (4), 252-257
- https://doi.org/10.1007/s11906-010-0126-2
Abstract
Key components of the metabolic syndrome (MetS), ie, obesity and insulin resistance, are associated with increased aldosterone production and mineralocorticoid receptor (MR) activation. Both MetS and hyperaldosteronism are proinflammatory and pro-oxidative states associated with cardiovascular disease. This review discusses emerging data that MR activation may contribute to abnormalities seen in MetS. In view of these data, MR antagonists may be beneficial in MetS, not only by controlling hypertension but also by reversing inflammation, oxidative stress, and defective insulin signaling at the cellular-molecular level. Clinical trials have demonstrated benefits of MR antagonists in heart failure, hypertension, and diabetic nephropathy, but additional trials are needed to demonstrate the clinical significance of MR blockade in MetS.Keywords
This publication has 50 references indexed in Scilit:
- Aldosterone-Induced Activation of Signaling Pathways Requires Activity of Angiotensin Type 1a ReceptorsCirculation Research, 2009
- New aspects of rapid aldosterone signalingMolecular and Cellular Endocrinology, 2009
- Impact of excess aldosterone on glucose homeostasis in adult male ratClinica Chimica Acta; International Journal of Clinical Chemistry, 2009
- Effect of Spironolactone on Left Ventricular Mass and Aortic Stiffness in Early-Stage Chronic Kidney Disease: A Randomized Controlled TrialJournal of the American College of Cardiology, 2009
- Blockade of mineralocorticoid receptor reverses adipocyte dysfunction and insulin resistance in obese miceCardiovascular Research, 2009
- Fasting Plasma Glucose and Serum Lipids in Patients With Primary AldosteronismHypertension, 2009
- Aldosterone and Cardiovascular DiseaseCurrent Problems in Cardiology, 2009
- Reconsidering the Roles of the Mineralocorticoid ReceptorHypertension, 2009
- Aldosterone Inhibits Insulin-Induced Glucose Uptake by Degradation of Insulin Receptor Substrate (IRS) 1 and IRS2 via a Reactive Oxygen Species-Mediated Pathway in 3T3-L1 AdipocytesEndocrinology, 2008
- The Heme Oxygenase System Abates Hyperglycemia in Zucker Diabetic Fatty Rats by Potentiating Insulin-Sensitizing PathwaysEndocrinology, 2008